Coventry Health Care: Managing Very Well

S&P says the managed-care outfit is poised to post solid earnings growthand it sports a compelling valuation

We think that managed-care company Coventry Health Care (CVH; recent price, $49) will continue to post respectable revenue and earnings growth over the next three years at least, owing to pricing discipline, cost controls, new products and services, and expansion into new geographies and market segments.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.